<DOC>
	<DOCNO>NCT02304575</DOCNO>
	<brief_summary>Testicular Cancer prevalent malignancy among men 20 34 year age , incidence rate rise western country include Israel . Cure rate testicular cancer exceed 90 % modern treatment . Thus issue quality life ( QoL ) , cop , effect couple relationship , cognitive function , cognitive orientation hormonal function become increasingly important . This study aim assess issue use validate , reproducible questionnaire hormonal plasma level , compare testicular cancer survivor control .</brief_summary>
	<brief_title>Quality Life Among Testicular Cancer Survivors</brief_title>
	<detailed_description>The study conduct RMC , Beilinson Golda . Eligible male patient list drawn Rabin Medical Center ( RMC ) operation room ' data system . Patients contact treat urologist phone follow-up visit invite take part research conduct RMC . The first stage study include validation EORTC QLQ-TC26 questionnaire Hebrew . Patients partner / spouse sign informed-consent form fill questionnaire visit , blood sample draw day questionnaire completion longer 1 month . Spouses give choice arrive patient filling-in questionnaire RMC , mail home . Research assistants provide assistance questionnaire . Normal control recruit among Tel Aviv University student , 'Achva ' College student RMS staff ask come RMC blood test . Control subject ask answer cancer-related questionnaire patient , fully possible , unless question irrelevant . The anticipated recruitment period approximately 36 month . Financial incentive : compensation 150 NIS offer healthy participant come RMC blood test study . Duration research participation : 1 2 encounter ( second miss data miss blood sample , first 30 patient - TC26 questionnaire re-validation EORTC requirement ) , longer 1 month participant . Measurements compare across patient 2 control group correlation hormonal function assess .</detailed_description>
	<mesh_term>Testicular Neoplasms</mesh_term>
	<mesh_term>Varicocele</mesh_term>
	<mesh_term>Testicular Hydrocele</mesh_term>
	<mesh_term>Spermatic Cord Torsion</mesh_term>
	<criteria>Group1 : Testicular cancer longterm survivor Male subject 2 10 year testicular cancer diagnosis , complete treatment regard complete responder . Able give inform consent Group 2 : Benign testicular condition patient Male subject 2 10 year testicular surgery due benign condition . Able give inform consent Group 3 : Healthy Controls Healthy male Able give inform consent Partners males 3 group Females male In couple relationship man 1 group , 1 year longer . Able give inform consent Exclusion criterion : Group1 : Testicular cancer longterm survivor Inability answer questionnaire ( i.e due mental impairment ) . Another malignancy , noninvasive skin basal cell carcinoma ( BCC ) squamous cell carcinoma ( SCC ) . Testicular cancer recurrence . Group 2 : Benign testicular condition patient Inability answer questionnaire . Any history malignancy noninvasive skin BCC SCC . Group 3 : Healthy Controls Inability answer questionnaire . Any history malignancy noninvasive skin BCC SCC . Any history testicular surgery diagnose testicular problem adulthood childhood . Partners males 3 group Inability answer questionnaire .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>